Dott.ssa Indini Alice
Doctor
Contacts
- Mail: alice.indini@istitutotumori.mi.it
Specialty / Department
- Medical Oncology
Medical oncologist with a strong clinical and academic background, specialised in melanoma, skin cancers, and immunotherapy.
Author and co-author of numerous peerreviewed international publications, with significant contributions that have advanced knowledge in immunotherapy, targeted therapies, and multidisciplinary cancer management.
Recognised as an invited speaker at major international oncology conferences, sharing expertise with both clinical and research communities.
Experienced in mentorship and training programmes for young oncologists and early-career researchers, actively supporting the development of the next generation of oncology specialists.
Member of the ESMO COTF (Community Oncologist Task Force). Actively involved in both national and European networks dedicated to Adolescents and Young Adults (AYA) with cancer, fostering collaboration and innovation in this emerging field.
Deeply engaged in clinical and translational research in melanoma and immuno-oncology, with a particular focus on immune-related toxicities, biomarkers of response and resistance, and survivorship issues.
- Mail: alice.indini@istitutotumori.mi.it
To book an appointment, you can use the online service (click here), contact the CUP on +39 0223901, or visit the Foundation’s reception desks in person.
Clinical Immunotherapy for Cancer and Innovative Therapies
Medical Oncology 1
Medical Oncology 1 – Medical Oncology Unit: Melanoma
Medical Oncology: Melanomas
Phase 1 Clinical Trials Unit (Early Clinical Drug Development Team – ECDD)
A Phase I/II, Open-Label, Multicenter Study of ALE.P02 (Claudin-1 Targeted Antibody-Drug Conjugate) as a Monotherapy in Adult Patients with Selected Advanced or Metastatic CLDN1+ Squamous Solid Tumors
Retrospective-Prospective Registry of Immune-Mediated Type 1 Diabetes in Solid Tumor Patients Treated with Immune Checkpoint Inhibitors
Last update: 04/06/2026